Columbia-Suicide Severity Risk Scale

Submitted by cbethel on
Abbreviation
C-SSRS
Description
The Columbia Protocol, also known as the Columbia-Suicide Severity Rating Scale (C-SSRS), supports suicide risk screening through a series of simple, plain-language questions that anyone can ask. The answers help users identify whether someone is at risk for suicide, determine the severity and immediacy of that risk, and gauge the level of support that the person needs. Users of the tool ask people: Whether and when they have thought about suicide (ideation) What actions they have taken — and when — to prepare for suicide Whether and when they attempted suicide or began a suicide attempt that was either interrupted by another person or stopped of their own volition
Category
Mental Health
Impulsivity and General Trait & Behavior Scales
Clinical Measures
Subcategory
Suicidal Intent

Rapid HIV Behavioral Assessment

Submitted by cbethel on
Abbreviation
RHBA
Description
Rapid HIV Behavioral Assessment (RHBA) is a method for collecting much-needed information about sexual, drug-use, and HIV testing behaviors from people at high risk for HIV infection in areas with low-to-moderate HIV prevalence. Data collected include demographics, sexual behaviors, injection drug use, non-injection drugs, HIV testing, STD diagnosis, and assessment of prevention services. (Gallagher, Denning, Allen, Nakashima, Sullivan, 2007)
Category
Impulsivity and General Trait & Behavior Scales
Physical/General Health
Sexual Behavior/HIV
Division
HEAL Study
Investigator(s)
Title
Using Social Media to Deliver HIV Self-Testing Kits and Link to Online PrEP Services (Social Media PrEP)
Short Description
The main objective of this study is to compare the effectiveness of HIV self-testing promotion between three web-based platforms: social media sites (Facebook, Instagram, Twitter) versus informational sites (Google, Bing, Yahoo) versus dating apps (Grindr/alternative, Hornet, Jack’d).
Release Date
Apr 09, 2025
Description
This project seeks to compare the relative effectiveness of using social media sites versus informational sites like to promote HIV self-testing and PrEP uptake. MSM between 18-30 years old will receive culturally-relevant advertisements targeting minorities similar to those previously developed. Specifically, the study aims to 1) adapt existing social media-based HIV self-testing and PrEP advertising materials for digital distribution on social media and informational sites and 2) compare the effectiveness of HIV testing and PrEP uptake promotion across social media sites versus online informational platforms.
Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Data
Study Links
Study Documents

Medical Mistrust Index

Submitted by cbethel on
Abbreviation
MMI
Description
The MMI was developed from a set of focus groups with patient/participants in a study of race differences in utilization of cardiovascular invasive procedures, and was further refined by a review of the literature on mistrust of societal institutions and mistrust of health care. (LaVeist, Isaac, Williams, 2009)
Category
Impulsivity and General Trait & Behavior Scales
Division
HEAL Study
Title
Opioid Use Disorder in the Emergency Department (ED-HEALTH)
Short Description
The purpose of this study is to evaluate the impact of (1) Implementation Facilitation (IF) on rates of provision of Emergency Department (ED)-initiated buprenorphine/naloxone (BUP) treatment with referral for ongoing medication-assisted treatment (MAT) and the (2) effectiveness of IF on patient engagement in formal addiction treatment at 30 days.
Release Date
Mar 21, 2025
Description
The study uses a Hybrid Type 3 Effectiveness-Implementation framework and a modified stepped wedge design. The study will be conducted at four EDs with a high prevalence of patients with untreated opioid use disorder (OUD). The four sites will receive the same sequence of evaluations and interventions: the baseline evaluation period after the standard dissemination practice, the IF phase, and continuation of facilitation into the IF evaluation period. The timing of initiation of the study activities at each site will be randomly offset by ~ 3 month increments to accommodate logistical constraints of simultaneous implementation at all sites. The study populations will include (1) ED providers and staff involved in the treatment of patients with OUD; (2) Community opioid treatment provider and program staff involved in providing care for patients with OUD referred from the ED; and (3) ED patients with moderate to severe OUD.
Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Data
Study Links
Study Documents